Skip to main content
Top
Published in: Pathology & Oncology Research 1/2017

01-01-2017 | Original Article

Clinicopathological Features and Treatment Analysis of Rare Aggressive Angiomyxoma of the Female Pelvis and Perineum – a Retrospective Study

Authors: Yin Sun, Lan Zhu, Xiaoyan Chang, Jie Chen, Jinghe Lang

Published in: Pathology & Oncology Research | Issue 1/2017

Login to get access

Abstract

The study was to evaluate the clinicopathological features of aggressive angiomyxoma (AAM) of the female pelvis and perineum and its treatments. This was a retrospective study of female patients with AAM admitted to our hospital. Clinical and pathological data were analyzed, as well as the postsurgical follow-up. Median age at initial presentation was 41 years. Thirteen patients had lesions involving adjacent organs. Eighteen patients underwent complete tumor resection, while one patient underwent partial tumor resection. The tumors were soft in texture, pink in color, and had mucus on the surface. A microscopic examination revealed that the tumors were non-encapsulated, with spindle cells and stellate cells of almost identical size loosely distributed in the myxoid stroma, and vessels of different sizes and wall thicknesses. Immunohistochemistry indicated that AAMs were strongly positive for CD34 and smooth muscle actin, moderately positive for desmin, estrogen receptors and progesterone receptor, and mostly negative for S-100. After a median follow-up of 24 months, the recurrence rate was 33.3 %. Four recurrences were in patients with positive initial margins. AAM is a slow growing, locally invasive, benign tumor. Complete resection could lead to lower recurrence rate compared with incomplete resection. Follow-up is necessary for recurrent cases with repeated surgeries. The overall prognosis could be favorable.
Literature
1.
go back to reference Steeper TA, Rosai J (1983) Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 7(5):463–475CrossRefPubMed Steeper TA, Rosai J (1983) Aggressive angiomyxoma of the female pelvis and perineum. Report of nine cases of a distinctive type of gynecologic soft-tissue neoplasm. Am J Surg Pathol 7(5):463–475CrossRefPubMed
2.
go back to reference Chan YM, Hon E, Ngai SW, Ng TY, Wong LC (2000) Aggressive angiomyxoma in females: is radical resection the only option? Acta Obstet Gynecol Scand 79(3):216–220CrossRefPubMed Chan YM, Hon E, Ngai SW, Ng TY, Wong LC (2000) Aggressive angiomyxoma in females: is radical resection the only option? Acta Obstet Gynecol Scand 79(3):216–220CrossRefPubMed
4.
go back to reference Piura B, Shaco-Levy R (2005) Pedunculated aggressive angiomyxoma arising from the vaginal suburethral area: case report and review of literature. Eur J Gynaecol Oncol 26(5):568–571PubMed Piura B, Shaco-Levy R (2005) Pedunculated aggressive angiomyxoma arising from the vaginal suburethral area: case report and review of literature. Eur J Gynaecol Oncol 26(5):568–571PubMed
5.
go back to reference Chihara Y, Fujimoto K, Takada S, Hirayama A, Cho M, Yoshida K, Ozono S, Hirao Y (2003) Aggressive angiomyxoma in the scrotum expressing androgen and progesterone receptors. Int J Urol 10(12):672–675CrossRefPubMed Chihara Y, Fujimoto K, Takada S, Hirayama A, Cho M, Yoshida K, Ozono S, Hirao Y (2003) Aggressive angiomyxoma in the scrotum expressing androgen and progesterone receptors. Int J Urol 10(12):672–675CrossRefPubMed
6.
go back to reference Baruah S, Latthe P, Bhatti NR, Ghataura SS (2004) Aggressive angiomyxoma of the vulva. Hosp Med 65(4):248–249CrossRefPubMed Baruah S, Latthe P, Bhatti NR, Ghataura SS (2004) Aggressive angiomyxoma of the vulva. Hosp Med 65(4):248–249CrossRefPubMed
7.
go back to reference Chen L, Schink JC, Panares BN, Barbuto D, Lagasse LD (1998) Resection of a giant aggressive angiomyxoma in the Philippines. Gynecol Oncol 70(3):435–439CrossRefPubMed Chen L, Schink JC, Panares BN, Barbuto D, Lagasse LD (1998) Resection of a giant aggressive angiomyxoma in the Philippines. Gynecol Oncol 70(3):435–439CrossRefPubMed
8.
go back to reference Jeyadevan NN, Sohaib SA, Thomas JM, Jeyarajah A, Shepherd JH, Fisher C (2003) Imaging features of aggressive angiomyxoma. Clin Radiol 58(2):157–162CrossRefPubMed Jeyadevan NN, Sohaib SA, Thomas JM, Jeyarajah A, Shepherd JH, Fisher C (2003) Imaging features of aggressive angiomyxoma. Clin Radiol 58(2):157–162CrossRefPubMed
9.
go back to reference Brunelle S, Bertucci F, Chetaille B, Lelong B, Piana G, Sarran A (2013) Aggressive angiomyxoma with diffusion-weighted magnetic resonance imaging and dynamic contrast enhancement: a case report and review of the literature. Case Rep Oncol 6(2):373–381. doi:10.1159/000353487 CrossRefPubMedPubMedCentral Brunelle S, Bertucci F, Chetaille B, Lelong B, Piana G, Sarran A (2013) Aggressive angiomyxoma with diffusion-weighted magnetic resonance imaging and dynamic contrast enhancement: a case report and review of the literature. Case Rep Oncol 6(2):373–381. doi:10.​1159/​000353487 CrossRefPubMedPubMedCentral
10.
go back to reference Smith HO, Worrell RV, Smith AY, Dorin MH, Rosenberg RD, Bartow SA (1991) Aggressive angiomyxoma of the female pelvis and perineum: review of the literature. Gynecol Oncol 42(1):79–85CrossRefPubMed Smith HO, Worrell RV, Smith AY, Dorin MH, Rosenberg RD, Bartow SA (1991) Aggressive angiomyxoma of the female pelvis and perineum: review of the literature. Gynecol Oncol 42(1):79–85CrossRefPubMed
11.
go back to reference Corson SL, Rosato EL, Rosato FE, Eschelman DJ (2002) Aggressive angiomyxoma of the pelvis: case report and review. Int J Fertil Womens Med 47(6):248–252PubMed Corson SL, Rosato EL, Rosato FE, Eschelman DJ (2002) Aggressive angiomyxoma of the pelvis: case report and review. Int J Fertil Womens Med 47(6):248–252PubMed
15.
go back to reference McCluggage WG, Patterson A, Maxwell P (2000) Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity. J Clin Pathol 53(8):603–605CrossRefPubMedPubMedCentral McCluggage WG, Patterson A, Maxwell P (2000) Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity. J Clin Pathol 53(8):603–605CrossRefPubMedPubMedCentral
16.
go back to reference Gungor T, Zengeroglu S, Kaleli A, Kuzey GM (2004) Aggressive angiomyxoma of the vulva and vagina. A common problem: misdiagnosis. Eur J Obstet Gynecol Reprod Biol 112(1):114–116CrossRefPubMed Gungor T, Zengeroglu S, Kaleli A, Kuzey GM (2004) Aggressive angiomyxoma of the vulva and vagina. A common problem: misdiagnosis. Eur J Obstet Gynecol Reprod Biol 112(1):114–116CrossRefPubMed
20.
go back to reference Htwe M, Deppisch LM, Saint-Julien JS (1995) Hormone-dependent, aggressive angiomyxoma of the vulva. Obstet Gynecol 86(4 Pt 2):697–699CrossRefPubMed Htwe M, Deppisch LM, Saint-Julien JS (1995) Hormone-dependent, aggressive angiomyxoma of the vulva. Obstet Gynecol 86(4 Pt 2):697–699CrossRefPubMed
22.
go back to reference Simo M, Zapata C, Esquius J, Domingo J (1992) Aggressive angiomyxoma of the female pelvis and perineum. Report of two cases and review of the literature. Br J Obstet Gynaecol 99(11):925–927CrossRefPubMed Simo M, Zapata C, Esquius J, Domingo J (1992) Aggressive angiomyxoma of the female pelvis and perineum. Report of two cases and review of the literature. Br J Obstet Gynaecol 99(11):925–927CrossRefPubMed
24.
go back to reference Steiner E, Schadmand-Fischer S, Schunk K, Bezzi I, Weikel W, Pilch H, Knapstein PG (2001) Perineal excision of a large angiomyxoma in a young woman following magnetic resonance and angiographic imaging. Gynecol Oncol 82(3):568–570. doi:10.1006/gyno.2001.6296 CrossRefPubMed Steiner E, Schadmand-Fischer S, Schunk K, Bezzi I, Weikel W, Pilch H, Knapstein PG (2001) Perineal excision of a large angiomyxoma in a young woman following magnetic resonance and angiographic imaging. Gynecol Oncol 82(3):568–570. doi:10.​1006/​gyno.​2001.​6296 CrossRefPubMed
26.
go back to reference Rhomberg W, Jasarevic Z, Alton R, Kompatscher P, Beer G, Breitfellner G (2000) Aggressive angiomyxoma: irradiation for recurrent disease. Strahlenther Onkol 176(7):324–326CrossRefPubMed Rhomberg W, Jasarevic Z, Alton R, Kompatscher P, Beer G, Breitfellner G (2000) Aggressive angiomyxoma: irradiation for recurrent disease. Strahlenther Onkol 176(7):324–326CrossRefPubMed
27.
28.
go back to reference Brooks SE, Balidimos I, Reuter KL, Khan A (1998) Virtual consult--aggressive angiomyxoma of the vulva: impact of GnRH agonists. Medscape Womens Health 3(3):4PubMed Brooks SE, Balidimos I, Reuter KL, Khan A (1998) Virtual consult--aggressive angiomyxoma of the vulva: impact of GnRH agonists. Medscape Womens Health 3(3):4PubMed
30.
go back to reference Behranwala KA, Thomas JM (2003) 'Aggressive' angiomyxoma: a distinct clinical entity. Eur J Surg Oncol 29(7):559–563CrossRefPubMed Behranwala KA, Thomas JM (2003) 'Aggressive' angiomyxoma: a distinct clinical entity. Eur J Surg Oncol 29(7):559–563CrossRefPubMed
32.
go back to reference Blandamura S, Cruz J, Faure Vergara L, Machado Puerto I, Ninfo V (2003) Aggressive angiomyxoma: a second case of metastasis with patient's death. Hum Pathol 34(10):1072–1074CrossRefPubMed Blandamura S, Cruz J, Faure Vergara L, Machado Puerto I, Ninfo V (2003) Aggressive angiomyxoma: a second case of metastasis with patient's death. Hum Pathol 34(10):1072–1074CrossRefPubMed
Metadata
Title
Clinicopathological Features and Treatment Analysis of Rare Aggressive Angiomyxoma of the Female Pelvis and Perineum – a Retrospective Study
Authors
Yin Sun
Lan Zhu
Xiaoyan Chang
Jie Chen
Jinghe Lang
Publication date
01-01-2017
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2017
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-016-0109-y

Other articles of this Issue 1/2017

Pathology & Oncology Research 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine